Play all audios:
Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this
journal Receive 24 print issues and online access $259.00 per year only $10.79 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now
Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer
support Authors * Rob J Mairs View author publications You can also search for this author inPubMed Google Scholar * MR Zalutsky View author publications You can also search for this author
inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Mairs, R., Zalutsky, M. New MIBG preparation to improve targeted radiotherapy and
reduce toxic side-effects in neuroblastoma patients undergoing combination treatment. _Br J Cancer_ 72, 250 (1995). https://doi.org/10.1038/bjc.1995.312 Download citation * Issue Date: 01
July 1995 * DOI: https://doi.org/10.1038/bjc.1995.312 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable
link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative